Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells.
Melatonin exerts oncostatic effects on different kinds of neoplasias, especially on oestrogen-dependent tumours. Recently, it has been described that melatonin, on the basis of its antioxidant properties, inhibits the growth of glioma cells. Glioma cells express oestrogen receptors and have the ability to synthesise oestrogens from androgens. In the present study, we demonstrate that pharmacological concentrations of melatonin decreases the growth of C6 glioma cells and reduces the local biosynthesis of oestrogens, through the inhibition of aromatase, the enzyme that catalyses the conversion of androgens into oestrogens. These results are supported by three types of evidence. Firstly, melatonin counteracts the growth stimulatory effects of testosterone on glioma cells, which is dependent on the local synthesis of oestrogens from testosterone. Secondly, we found that melatonin reduces the aromatase activity of C6 cells, measured by the tritiated water release assay. Finally, by (RT)-PCR, we found that melatonin downregulates aromatase mRNA steady-state levels in these glioma cells. We conclude that melatonin inhibits the local production of oestrogens decreasing aromatase activity and expression. By analogy to the implications of aromatase in other forms of oestrogen-sensitive tumours, it is conceivable that the modulation of the aromatase by pharmacological melatonin may play a role in the growth of glioblastomas.
González
A
A
Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, Santander, Spain.
Martínez-Campa
C
C
Mediavilla
M D
MD
Alonso-González
C
C
Sánchez-Barceló
E J
EJ
Cos
S
S
D000818:Animals; D001141:Aromatase / Q000187:drug effects* / Q000378:metabolism*; D015536:Down-Regulation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology*; D004967:Estrogens / Q000096:biosynthesis; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D005910:Glioma / Q000188:drug therapy / Q000201:enzymology*; D008550:Melatonin / Q000008:administration & dosage* / Q000494:pharmacology*; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
D004791:Enzyme Inhibitors; D004967:Estrogens; D001141:Aromatase; D008550:Melatonin
Breast Cancer Res Treat. 1997 May;44(1):57-64
9164678
Cell Growth Differ. 1997 Nov;8(11):1225-40
9372245
Cancer Res. 1998 Oct 1;58(19):4383-90
9766668
Clin Cancer Res. 1999 Sep;5(9):2366-73
10499606
Free Radic Biol Med. 2004 Dec 1;37(11):1790-801
15528038
J Pineal Res. 2005 Mar;38(2):136-42
15683469
J Neural Transm (Vienna). 1999;106(9-10):883-8
10599870
Int J Dev Neurosci. 2000 Apr-Jun;18(2-3):289-97
10715583
Front Neuroendocrinol. 2000 Apr;21(2):133-70
10764528
Prostate. 2005 Apr 1;63(1):29-43
15378522
J Pineal Res. 2005 May;38(4):217-22
15813897
Int J Cancer. 2006 Jan 15;118(2):274-8
16080194
J Neurochem. 2005 Dec;95(5):1227-36
16313512
Breast Cancer Res Treat. 2005 Dec;94(3):249-54
16244789
Neuroscience. 2006;137(1):197-209
16289585
Cancer Res. 2006 Jan 15;66(2):1081-8
16424044
Endocrinology. 2006 Apr;147(4):1796-804
16439453
Cancer Detect Prev. 2006;30(2):118-28
16647824
J Pineal Res. 2006 Sep;41(2):130-5
16879318
J Toxicol Environ Health A. 2007 Jan;70(1):19-27
17162496
J Neurochem. 2007 Feb;100(3):736-46
17263795
J Pineal Res. 2007 Mar;42(2):113-8
17286741
Histol Histopathol. 2000 Apr;15(2):637-47
10809385
Eur J Endocrinol. 2001 Dec;145(6):669-79
11720889
Curr Top Med Chem. 2002 Feb;2(2):113-32
11899096
Neuroreport. 2002 Mar 25;13(4):473-5
11930164
J Androl. 2002 Jul-Aug;23(4):572-8
12065466
Brain Res. 2003 May 9;971(2):178-88
12706234
Endocr Relat Cancer. 2003 Jun;10(2):153-9
12790777
Endocr Res. 2003 Nov;29(4):399-410
14682469
Ann N Y Acad Sci. 2003 Dec;1007:64-78
14993041
Neurochem Res. 2004 Jul;29(7):1359-64
15202765
J Biol Chem. 2004 Sep 10;279(37):38294-302
15229223
Neurosci Lett. 2004 Sep 30;368(3):279-84
15364411
Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1583-8
15466973
J Clin Endocrinol Metab. 1981 Aug;53(2):412-7
7251819
Clin Neuropharmacol. 1984;7(4):395-7
6595057
J Reprod Fertil. 1986 Nov;78(2):711-7
3806524
J Pineal Res. 1991 Jan;10(1):36-42
2056430
Andrologia. 1991 May-Jun;23(3):227-31
1741487
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):621-31
1562533
Steroids. 1991 Nov;56(11):538-43
1814018
J Steroid Biochem Mol Biol. 1992 May;42(3-4):267-77
1606040
J Steroid Biochem Mol Biol. 1994 Jan;48(1):145-54
8136300
J Neurochem. 1994 Dec;63(6):2058-64
7964723
Oncology. 1996 Jan-Feb;53(1):43-6
8570130
Brain Res. 1996 Feb 26;710(1-2):143-9
8963653
Epidemiol Rev. 1995;17(2):382-414
8654518
J Steroid Biochem Mol Biol. 1993 Aug;46(2):147-53
8664162
Brain Res Brain Res Rev. 1996 Jun;22(1):1-26
8871783
Neurosci Lett. 1996 Sep 27;216(2):113-6
8904796